Details

Autor(en) / Beteiligte

• Calixto-Lima, Larissa
• Wiegert, Emanuelly Varea Maria
• de Oliveira, Livia Costa
• Chaves, Gabriela Villaça
• Avesani, Carla Maria
• Bezerra, Flavia Fioruci

Titel

Factors associated with variability in skeletal muscle radiodensity in patients with metastatic cancer

Ist Teil von

• Nutrition (Burbank, Los Angeles County, Calif.), 2024-04, Vol.120, p.112351-112351, Article 112351

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• •Lower skeletal muscle radiodensity was associated with age ≥60 y, White race/skin color, primary tumor located in the gynecologic area or bone and connective tissues, and presence of kidney disease.•Body mass index and adipose tissue markers were positively associated with SMD skeletal muscle radiodensity.•Serum albumin, skeletal muscle index, and handgrip strength were inversely associated with skeletal muscle radiodensity. This study aimed to explore factors associated with skeletal muscle radiodensity (SMD) variability in patients with metastatic cancer. This study included 393 patients (median age 61 y, 70% women) who had computed tomography (CT) scans within 30 days of inclusion in the study. SMD was evaluated from CT by averaging the Hounsfield unit value of the total muscle area. Skeletal muscle index (SMI), visceral adipose tissue index (VATI), subcutaneous adipose tissue index (SATI), and total adipose tissue index (TATI) were also assessed by CT. Additionally, age, sex, race/skin color, disease characteristics, comorbidities, inflammatory markers, handgrip strength (HGS), and body mass index (BMI) were recorded and evaluated in the linear regression analysis to identify factors associated with SMD variability. Multivariate explanatory models having SMD as an independent variable were performed and included BMI (model 1, r2 = 0.699), TATI (model 2, r2 = 0.712) or VATI and SATI (model 3, r2 = 0.706) in addition to age, race/skin color, tumor site, kidney disease, serum albumin, HGS, and SMI as dependent variables. For all models, lower SMD was associated with higher age, BMI, and adiposity measurements, kidney disease, White race/skin color, and lower serum albumin, HGS, and SMI. The primary tumor site also contributed to changes in SMD in all models, specifically those located in the gastrointestinal tract, gynecologic, and bone and connective tissue. Conclusion: In this group of patients with metastatic cancer, lower SMD was associated with older age, White race/skin color, and an overall worse clinical condition.